U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07330024) titled 'Evaluation of Pulpal and Salivary Neuropeptides in Dental Pain' on Dec. 12, 2025.
Brief Summary: This observational cross-sectional study is designed to evaluate pulpal and salivary levels of Substance P (SP) and Calcitonin Gene-Related Peptide (CGRP) in individuals with and without dental pain. The study aims to assess the associations between neuropeptide levels, pain severity, histopathological pulpal inflammation, and psychological status including depression, anxiety, and stress. By integrating biological and psychosocial parameters, this study seeks to contribute to a comprehensive understanding of the multifactorial nature of...